QR12000 compound tablets

QR12000 · Wuhan Createrna Science and Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QR12000 compound tablets, covering 2024-12-06 to 2024-12-06. Get the full timeline:

Most recent: Clinical Trial Update: QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension [Phase 3]